Jonathan Ang

Jonathan joined Polaris Partners in 2023 and serves as an entrepreneur partner in the firm’s Singapore research office. In this role, he focuses on building and supporting healthcare companies. He currently works with Polaris portfolio companies including Sunbird Bio and Maxcess Health.

Prior to Polaris, Jonathan was Director in the Life Sciences Team at Temasek International in Singapore, where he managed the firm’s global health care services investment strategy. He co-led investments in the U.S., India, China, Southeast Asia and Latin America. Jonathan was a board observer on several portfolio companies including Columbia Asia Hospitals, Halodoc, Iora Health, Quintiles Transnational Corp., and Zuellig Pharma Holdings Pte Ltd.

Earlier, Jonathan worked at Cowen’s Health Care Banking Team in New York and London, executing mergers and acquisitions, IPOs and private placements.

Jonathan graduated with honors in Economics, majoring in Finance and Accounting, from The Wharton School of the University of Pennsylvania.